Standout Papers

Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenz... 2000 2026 2008 2017 769
  1. Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza (2000)
    John J. Treanor, Frederick G. Hayden et al. JAMA
  2. Oral oseltamivir treatment of influenza in children (2001)
    Richard J. Whitley, Frederick G. Hayden et al. The Pediatric Infectious Disease Journal
  3. Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial (2013)
    Jeffrey L. Cummings, Stuart Isaacson et al. The Lancet

Immediate Impact

35 from Science/Nature 92 standout
Sub-graph 1 of 18

Citing Papers

Airborne transmission of respiratory viruses
2021 StandoutScience
Disruption of mitochondrial complex I induces progressive parkinsonism
2021 StandoutNature
8 intermediate papers

Works of Roger Mills being referenced

Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial
2013 Standout
Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis
2009
and 2 more

Author Peers

Author Last Decade Papers Cites
Roger Mills 607 325 1970 517 20 3.2k
Fred Y. Aoki 241 104 2593 960 73 3.8k
David Hopkins 487 373 419 1012 87 4.3k
Sonia Villapol 2565 452 556 1019 65 5.2k
Carlo Di Pietrantonj 179 126 2834 743 52 4.5k
Tomoko Udo 439 181 280 1326 41 3.5k
Li He 683 110 272 896 63 2.4k
Lok Ting Lau 195 54 580 550 55 2.5k
Annie Lannuzel 789 68 342 302 65 2.3k
Stephen Toovey 116 111 730 572 80 2.7k
Michel Vaillant 395 277 806 301 118 3.2k

All Works

Loading papers...

Rankless by CCL
2026